North East and North Cumbria
ICS Formulary
2 Cardiovascular system
02-05-05-03 Renin inhibitors
Aliskiren
Non Formulary
Note:
not to be prescribed in new patients (July 2019).
Existing patients should be reviewed to evaluate ongoing care plans
Items not to be routinely prescribed in primary care
Links
Academic Health Science Network (North East and North Cumbria) - Atrial Fibrilation
County Durham and Darlington DVT Pathway Information
County Durham and Tees Valley Prescribing Guideline for the Use of Anticoagulants in Non-Valvular Atrial Fibrillation
Items not to be routinely prescribed in primary care
MHRA Drug Safety Update (Dec 2016): Spironolactone and renin-angiotensin system drugs in heart failure: risk of potentially fatal hyperkalaemia—clarification, December 2016
MHRA Drug Safety Update (Feb 2016): Spironolactone and renin-angiotensin system drugs in heart failure: risk of potentially fatal hyperkalaemia.
MHRA Drug Safety Update (June 2014): Combination use of medicines from different classes of renin-angiotensin system blocking agents: risk of hyperkalaemia, hypotension, and impaired renal function—new warnings
NICE NG148: Acute kidney injury: prevention, detection and management
NICE NG191: COVID-19 rapid guideline: managing COVID-19
North Cumbria - Cardiovascular workplan 2022
South Tees Hospitals Cardiology drug prescribing guidelines & formulary
Key
Full Site